首页> 外文期刊>Ultraschall in der Medizin: Organ der Deutschen Gesellschaft fu?r Ultraschall in der Medizin, [der] O?sterreichischen Gesellschaft fu?r Ultraschall in der Medizin, [der] Schweizerischen Gesellschaft fu?r Ultraschall in Medizin und Biologie >Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
【24h】

Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?

机译:在超声中偶然发现脾脏病变:超声造影是否能改善良性血管瘤/血管瘤与恶性病变的鉴别?

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The aim of the study was to identify and validate enhancing features for differentiating benign vascular neoplasms of the hemangioma/hamartoma type from malignant splenic lesions on contrast-enhanced ultrasonography (CEUS). MATERIALS AND METHODS: 136 splenic lesions (58 benign vascular neoplasms, 78 malignant) in 136 patients underwent baseline US and pulse-inversion CEUS after sulfur hexafluoride-filled microbubble injection. Two on-site readers assessed lesion enhancement features during arterial and parenchymal phase in consensus. Best predicting CEUS features for lesion diagnosis were identified through univariate and multivariate analyses. Two blinded off-site readers independently issued a confidence rating for lesion diagnosis in baseline US and CEUS using extracted diagnostic CEUS features. Diagnostic performance, receiver operating curves (Az-value), and interreader agreement were calculated. The reference standards were histopathology or CT and/or MR imaging with clinical follow-up. RESULTS: Multivariate analysis outlined arterial hyperenhancement or isoenhancement to be an independent CEUS predictor of benign vascular neoplasms (odds ratio, 3.558; p < 0.0017). Within the subgroup of isoechoic or hypoechoic lesions, arterial hyperenhancement was virtually diagnostic for benign vascular neoplasm (odds ratio, 21.333; p < 0.001). The diagnostic accuracy and confidence (Az-value) of the two readers was 63.2 % and 70.6 % (0.785 and 0.818) for baseline US, which improved significantly to 87.5 % and 88.2 % (0.915 and 0.908) for CEUS (p < 0.001). Interreader agreement also increased with CEUS ( = 0.88) compared to baseline US ( = 0.52). CONCLUSION: Sulfur hexafluoride-enhanced CEUS improves differentiation between benign vascular and malignant splenic tumors and may be especially useful in clinical scenarios in which the incidental hypoechoic splenic lesion is unclear on conventional US.
机译:目的:本研究的目的是在超声造影(CEUS)上鉴定和验证用于区分血管瘤/血管瘤类型的良性血管瘤与恶性脾脏病变的增强特征。材料与方法:136例患者中的136例脾脏病变(58例良性血管肿瘤,78例恶性肿瘤)在注入六氟化硫微泡后进行了基线US超声和CEUS脉冲反转。两位现场读者以一致的方式评估了动脉和实质阶段的病变增强特征。通过单因素和多因素分析可确定对病变诊断最能预测的CEUS特征。两个盲人的异地阅读器使用提取的诊断性CEUS功能独立发布了基线US和CEUS病变诊断的置信度。计算诊断性能,接收器工作曲线(Az值)和阅读器间一致性。参考标准是组织病理学或CT和/或MR成像并进行临床随访。结果:多因素分析概述动脉过度增强或同等增强是CEUS良性血管肿瘤的独立预测因子(比值比为3.558; p <0.0017)。在等回声或低回声病变的亚组中,动脉过度增强实际上可诊断出良性血管肿瘤(比值比为21.333; p <0.001)。两个阅读器的诊断准确度和置信度(A​​z值)对基线US分别为63.2%和70.6%(0.785和0.818),对于CEUS显着提高至87.5%和88.2%(0.915和0.908)(p <0.001) 。与基线US(= 0.52)相比,CEUS(= 0.88)的阅读器一致性也有所提高。结论:六氟化硫增强的CEUS可以改善良性血管和恶性脾脏肿瘤之间的区别,在常规美国尚不清楚偶发性低回声脾脏病变的临床情况中尤其有用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号